NOTUS News, June 26, 2025: NOTUS news article gives numerous examples from experts who agree with RFK Jr and Makary criticisms of corporate influence on health, but say HHS plans to reduce conflicts of interest are ineffective and FDA remains overly influenced by industry.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Biotech pauses trial after second patient death linked to gene therapy
The Washington Post, June 17, 2025; Sarepta restricts Elevidys gene therapy for non-ambulatory Duchenne muscular dystrophy patients after second death. We point out that FDA flexibility “does no favor” to patients who may die from using a questionable treatment. Elevidys costs $3.2 million per patient.
Read More »FDA Approved — And Ineffective
June 5, 2025: New report in The Lever shows that most drugs approved by the FDA do not meet the standards of evidence required by law and we say that the FDA’s standards are the lowest ever
Read More »Right Diagnosis, Wrong Prescription: Experts Weigh In on RFK, Jr’s Food Safety and Nutrition Policies
Medscape, June 4, 2025: NCHR and other experts agree that RFK Jr plans to improve food safety deserve attention, but debate whether these plans benefit nutrition or will be defeated by anti-regulatory pressure from the White House and Republicans in Congress.
Read More »Trump’s diversity purge freezes hundreds of millions in medical research at universities across the country
CNN reports how cuts in university research projects harm important efforts to improve health and save lives in red and blue states. NCHR says researchers are scared about the future of their work and explains how important it is to study differences in how patients develop diseases and which treatments are most effective. We suggest that studies using terms like diversity could be funded if described accurately but with different wording.
Read More »